Delek US Holdings, Inc. Quarterly Cost of Revenue in USD from Q3 2017 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Delek US Holdings, Inc. quarterly/annual Cost of Revenue history and growth rate from Q3 2017 to Q3 2024.
  • Delek US Holdings, Inc. Cost of Revenue for the quarter ending September 30, 2024 was $3.06B, a 29.6% decline year-over-year.
  • Delek US Holdings, Inc. Cost of Revenue for the twelve months ending September 30, 2024 was $13.7B, a 17.4% decline year-over-year.
  • Delek US Holdings, Inc. annual Cost of Revenue for 2023 was $16.2B, a 16.2% decline from 2022.
  • Delek US Holdings, Inc. annual Cost of Revenue for 2022 was $19.3B, a 86% increase from 2021.
  • Delek US Holdings, Inc. annual Cost of Revenue for 2021 was $10.4B, a 37.5% increase from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $13.7B $3.06B -$1.29B -29.6% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $14.9B $3.37B -$673M -16.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $15.6B $3.1B -$590M -16% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $16.2B $4.13B -$329M -7.37% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 $16.5B $4.35B -$833M -16.1% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $17.4B $4.04B -$1.3B -24.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $18.7B $3.69B -$670M -15.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $19.3B $4.46B +$1.41B +46.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 $17.9B $5.18B +$2.35B +82.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $15.6B $5.34B +$3.19B +148% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $12.4B $4.36B +$1.99B +84.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $10.4B $3.04B +$1.05B +53% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 $9.34B $2.84B +$785M +38.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $8.56B $2.15B +$717M +50% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 $7.84B $2.37B +$278M +13.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $7.56B $1.99B -$143M -6.69% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 $7.71B $2.05B -$98.6M -4.59% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 $7.8B $1.43B -$811M -36.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $8.62B $2.09B +$207M +11% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $8.41B $2.13B -$70.2M -3.19% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-25
Q3 2019 $8.48B $2.15B -$272M -11.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $8.75B $2.25B -$176M -7.26% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 $8.93B $1.88B -$334M -15.1% Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $9.26B $2.2B Oct 1, 2018 Dec 31, 2018 10-K 2021-03-01
Q3 2018 $2.42B +$238M +10.9% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 $2.42B Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $2.21B Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q3 2017 $2.18B Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.